Education
About Us
Working with TipRanks
Follow Us
Helius Medical Technologies (HSDT)
NASDAQ:HSDT
Total Valuation
Helius Medical Technologies has a market cap or net worth of $183.36M. The enterprise value is -$4.96M.
Market Cap$183.36M
Enterprise Value-$4.96M
Share Statistics
Helius Medical Technologies has 40,299,220 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,299,220
Owned by Insiders0.96%
Owned by Institutions22.18%
Financial Efficiency
Helius Medical Technologies’s return on equity (ROE) is -11.09 and return on invested capital (ROIC) is -990.95%.
Return on Equity (ROE)-11.09
Return on Assets (ROA)-3.32
Return on Invested Capital (ROIC)-990.95%
Return on Capital Employed (ROCE)-10.08
Revenue Per Employee24.76K
Profits Per Employee-559.14K
Employee Count21
Asset Turnover0.15
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of Helius Medical Technologies is ―. Helius Medical Technologies’s PEG ratio is 2.86.
PE Ratio―
PS Ratio2618.59
PB Ratio1.29K
Price to Fair Value1.29K
Price to FCF-123.27
Price to Operating Cash Flow>-0.01
PEG Ratio2.86
Income Statement
In the last 12 months, Helius Medical Technologies had revenue of 520.00K and earned -11.74M in profits. Earnings per share was -4.33.
Revenue520.00K
Gross Profit-62.00K
Operating Income-13.90M
Pretax Income-11.74M
Net Income-11.74M
EBITDA-13.80M
Earnings Per Share (EPS)-4.33
Cash Flow
In the last 12 months, operating cash flow was -12.71M and capital expenditures 0.00, giving a free cash flow of -12.71M billion.
Operating Cash Flow-12.71M
Free Cash Flow-12.71M
Free Cash Flow per Share-0.32
Dividends & Yields
Helius Medical Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change-99.11%
50-Day Moving Average8.66
200-Day Moving Average105.52
Relative Strength Index (RSI)39.23
Average Volume (3m)1.55M
Important Dates
Helius Medical Technologies upcoming earnings date is May 7, 2026, TBA (Confirmed).
Last Earnings DateNov 18, 2025
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Helius Medical Technologies as a current ratio of 1.58, with Debt / Equity ratio of 0.00%
Current Ratio1.58
Quick Ratio1.10
Debt to Market Cap<0.01
Net Debt to EBITDA0.08
Interest Coverage Ratio-817.82
Taxes
In the past 12 months, Helius Medical Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Helius Medical Technologies EV to EBITDA ratio is -98.57, with an EV/FCF ratio of -123.17.
EV to Sales2.62K
EV to EBITDA-98.57
EV to Free Cash Flow-123.17
EV to Operating Cash Flow-123.23
Balance Sheet
Helius Medical Technologies has $124.05M in cash and marketable securities with $0.00 in debt, giving a net cash position of $124.05M billion.
Cash & Marketable Securities$124.05M
Total Debt$0.00
Net Cash$124.05M
Net Cash Per Share$3.08
Tangible Book Value Per Share$0.39
Margins
Gross margin is 49.63%, with operating margin of -2673.65%, and net profit margin of -2258.08%.
Gross Margin49.63%
Operating Margin-2673.65%
Pretax Margin-2258.08%
Net Profit Margin-2258.08%
EBITDA Margin-2654.42%
EBIT Margin-2665.96%
Analyst Forecast
The average price target for Helius Medical Technologies is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price Target―
Price Target Upside―
Analyst ConsensusModerate Sell
Analyst Count0
Revenue Growth Forecast87.45%
EPS Growth Forecast72.30%